Gross margin from €18,642 to €21,025Registered office moved within Visé14-03Debts from €227,774 to €310,901Investments €73,103Cash from €22,585 to €52,413
MAES PHARMCONSULT pays its suppliers 200 days later than in 2024.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0875845464
Registered office moved within Visé
The registered office moved from rue de Maastricht 5, 4600 Visé to rue de Dalhem n°5, 4600 Visé · General meeting of 04-02-2025 · Gazette deed
Hidden nameVisible after signing in changes role from manager to directorName after signing inVisible after signing in acts as permanent representative · Discharge granted to Name hiddenVisible after signing in (manager) · General meeting of 20-12-2023 · Gazette deed
Registered office moved from Trooz to Visé
The registered office moved from RUE GRIHANSTER, 22-4870 TROOZ to rue de Maastricht 5, 4600 Visé · Hidden nameVisible after signing in resigns as director · General meeting of 17-05-2022 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as MAES PHARMCONSULT: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €427,000 and €484,000, founded between 2005 and 2007.
The company number of MAES PHARMCONSULT is 0875.845.464. The VAT number is the same number with BE in front: BE 0875.845.464.
Where is MAES PHARMCONSULT based?
The registered office is at Rue de Dalhem 5, 4600 Visé.Company details
What does MAES PHARMCONSULT do?
According to the KBO register, the main activity is business and other management consultancy (NACE 70200).
What is the legal form of MAES PHARMCONSULT?
MAES PHARMCONSULT is a private limited company (BV).
When was MAES PHARMCONSULT founded?
MAES PHARMCONSULT was founded on 24-08-2005.
Is MAES PHARMCONSULT still active?
Yes, MAES PHARMCONSULT is an active enterprise in the KBO register.
What is the turnover of MAES PHARMCONSULT?
The turnover in financial year 2025 is about €95,000. This figure is estimated from the gross margin of €21,025 and 257 comparable companies (NACE 70200). It probably lies between €42,000 and €190,000. It is a rough estimate. In financial year 2020 turnover was €181,161.Financials
Is MAES PHARMCONSULT profitable?
In financial year 2025, MAES PHARMCONSULT made a profit of €3,689.
Where can I find the annual accounts of MAES PHARMCONSULT?
MAES PHARMCONSULT filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MAES PHARMCONSULT due?
MAES PHARMCONSULT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline